Hantz Financial Services, Inc. Astrazeneca PLC Transaction History

Hantz Financial Services, Inc.

$5.74 Billion
Q4 2024

A detailed history of Hantz Financial Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 45,726 shares of AZN stock, worth $3.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

45,726

Previous 44,514 2.72%

Holding current value

$3.5 Million

Previous $3.47 Million 13.61%

% of portfolio

0.05%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 23, 2025	BUY	$63.2 - $79.58 $76,598 - $96,450	1,212 Added 2.72%	45,726 $3 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $30,821 - $35,223	402 Added 0.91%	44,514 $3.47 Million
Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $2.95 Million - $3.57 Million	44,112 New	44,112 $3.44 Million
Q1 2024 Aug 06, 2024	SELL	$61.03 - $69.57 $119,740 - $136,496	-1,962 Reduced 4.16%	45,238 $3.07 Million
Q4 2023 Aug 06, 2024	BUY	$61.89 - $69.28 $2.91 Million - $3.26 Million	46,986 Added 21956.07%	47,200 $3.18 Million
Q2 2023 Aug 06, 2024	SELL	$69.91 - $75.81 $11,744 - $12,736	-168 Reduced 43.98%	214 $15,000
Q1 2023 Aug 06, 2024	BUY	$63.15 - $71.6 $126 - $143	2 Added 0.53%	382 $27,000
Q4 2022 Aug 06, 2024	SELL	$54.21 - $70.44 $11,058 - $14,369	-204 Reduced 34.93%	380 $26,000
Q3 2022 Aug 06, 2024	BUY	$53.02 - $135.75 $7,793 - $19,955	147 Added 33.64%	584 $32,000
Q2 2022 Aug 06, 2024	SELL	$59.26 - $71.14 $592 - $711	-10 Reduced 2.24%	437 $29,000
Q1 2022 Aug 06, 2024	SELL	$55.72 - $67.12 $1,225 - $1,476	-22 Reduced 4.69%	447 $30,000
Q4 2021 Aug 06, 2024	SELL	$54.02 - $63.83 $1,026 - $1,212	-19 Reduced 3.89%	469 $27,000
Q3 2021 Aug 06, 2024	BUY	$55.56 - $60.79 $15,779 - $17,264	284 Added 139.22%	488 $29,000
Q1 2021 Aug 06, 2024	SELL	$47.16 - $54.44 $2.07 Million - $2.39 Million	-43,908 Reduced 99.54%	204 $10,000
Q3 2020 Aug 06, 2024	BUY	$53.07 - $61.1 $2,175 - $2,505	41 Added 20.1%	245 $13,000
Q2 2020 Aug 06, 2024	SELL	$43.1 - $55.31 $1.89 Million - $2.43 Million	-43,908 Reduced 99.54%	204 $11,000

Others Institutions Holding AZN

# of Institutions

1,368

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $237B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Astrazeneca PLC Transaction History